Radiofrequency ablation in high-risk stage I non–small cell lung cancer

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|19|3393-3394

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.19, 2015-10, pp. : 3393-3394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Radiofrequency ablation of stage IA non–small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3491-3498

Blackwell Publishing

Access to resources Recommend Favorite

Comparative effectiveness of surgery and radiosurgery for stage I non–small cell lung cancer

By  

Cancer, Vol. 121, Iss. 14, 2015-07 ,pp. : 2341-2349

Blackwell Publishing

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite

Economics of Treatments for Non-Small Cell Lung Cancer

By Chouaid Christos   Atsou Kukovi  

PharmacoEconomics, Vol. 27, Iss. 2, 2009-01 ,pp. : 113-125

Adis International

Access to resources Recommend Favorite